2-amino-5-phosphonovalerate has been researched along with Blood Pressure, Low in 3 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashim, MA | 1 |
| Tadepalli, AS | 1 |
| Canesin, RO | 1 |
| Bonagamba, LG | 1 |
| Machado, BH | 1 |
| Hong, LZ | 1 |
| Cheng, PW | 1 |
| Cheng, WH | 1 |
| Chen, SR | 1 |
| Wang, LL | 1 |
| Tseng, CJ | 1 |
3 other studies available for 2-amino-5-phosphonovalerate and Blood Pressure, Low
| Article | Year |
|---|---|
Hypotension to central endothelin-1: effect of glutamate receptor blockade.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Dizocilpine Maleate; End | 1994 |
Bradycardic and hypotensive responses to microinjection of L-glutamate into the lateral aspect of the commissural NTS are blocked by an NMDA receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Blood Pressure; Bradycardia; Excitatory Amino Acid Antagonists | 2000 |
Involvement of NMDA receptors in nicotine-mediated central control of hypotensive effects.
Topics: Animals; Blood Pressure; Bradycardia; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid | 2012 |